Research Watch
Phase III, finally: what the latest trial readout means
A landmark depression trial just reported. We read the actual paper so you don't have to — what's solid, what's still open.
A large, controlled trial has reported results for psilocybin-assisted therapy in treatment-resistant depression. We walk through the design, the effect size, and the caveats that matter before anyone calls it settled.


